Nanalysis宣布发布自动化软件-动脉网

Nanalysis Announces Release of Automation Software

CISION 等信源发布 2025-03-18 20:30



可切换为仅中文







Provides Ease of Use and Reduces Expertise Required to Collect Data

提供易用性并减少收集数据所需的专业知识

CALGARY, AB

卡尔加里，阿尔伯塔省

，

March 18, 2025

2025年3月18日

/PRNewswire/ -

Nanalysis Scientific Corp.

纳分析科学公司

('the Company',

（“公司”，

TSXV: NSCI

，

OTCQX:

场外交易市场QX：

NSCIF

，

FRA: 1N1

法国：1N1

), a leader in portable NMR instruments and imaging technology and services for industrial and research applications, announces the release of automation software to reduce the barrier of expertise required to generate quantitative data.

便携式核磁共振仪器和成像技术及服务的领导者，为工业和研究应用提供解决方案，宣布推出自动化软件以降低生成定量数据所需的专业门槛。

'It has long been the vision for Nanalysis to proliferate the use of NMR Spectroscopy into industrial quality control and quality assurance,' said

“Nanalysis 的愿景一直是将核磁共振波谱技术推广到工业质量控制和质量保证领域，”

Sean Krakiwsky

肖恩·克拉基夫斯基

, Founder and CEO of Nanalysis. 'While NMR is often considered the most information rich technique, it is not frequently incorporated into routine QA/QC because of the requirements of larger legacy NMR instrumentation that are not practical in many environments, including manufacturing and QA/QC laboratories. Additionally, the large barrier of expertise required to maintain equipment, acquire and analyze NMR data has been limiting. Our novel benchtop NMR products provide high quality data that have been proven to work well in these applications, as illustrated, for example, in our previous work with the USP for quantification of active pharmaceutical ingredients. Now, through the addition of onboard software solutions, we can streamline the data analysis and reduce the barrier of expertise required to introduce these instruments into testing and measurement laboratories.'.

Nanalysis创始人兼首席执行官表示：“尽管核磁共振（NMR）通常被认为是最富信息的技术，但由于大型传统核磁共振仪器的要求在许多环境中并不实用，包括制造和质量保证/质量控制实验室，它并未被广泛纳入常规的质量保证/质量控制流程中。此外，维护设备、获取和分析核磁共振数据所需的高技术门槛也成为了限制因素。我们新颖的台式核磁共振产品提供了高质量的数据，并已被证明在这些应用中表现优异，例如，我们在之前与美国药典（USP）合作进行活性药物成分定量的工作中已有所体现。现在，通过增加机载软件解决方案，我们可以简化数据分析过程，并降低将这些仪器引入测试和测量实验室所需的技术门槛。”

The new software, called the qNMR module, is an automated, easy-to-use software module to allow users to create and edit methods for routine qNMR assays. This allows technicians to collect data effortlessly, with no expertise in NMR spectroscopy required. The module has been designed to work with both our 100 MHz product, and our recently released 60 MHz, as well as in conjunction with autosamplers for higher throughput.

新的软件被称为qNMR模块，是一个自动化、易于使用的软件模块，允许用户创建和编辑用于常规qNMR分析的方法。这使得技术人员可以轻松收集数据，而无需具备NMR光谱学的专业知识。该模块设计用于与我们的100 MHz产品和最近发布的60 MHz产品配合使用，并且可与自动进样器结合使用以实现更高的通量。

A full description and video can be found on our website here: .

完整描述和视频可以在我们的网站上找到，点击这里：。

https://www.nanalysis.com/qnmr

。

Dr.

博士

Susanne D. Riegel

苏珊·D·里格尔

, Nanalysis VP Marketing & NMR Product Manager says, 'To expand the use of our compact and portable benchtop NMR platforms into industrial QA/QC we have employed a four-pronged approach: 1) identify and validate methods which have a strong ROI for modernizing the incumbent method to benchtop NMR; 2) provide good data handling practices to ensure data integrity requirements are met; 3) explore regulation compliance of these methods; and, finally, 4) reduce the barrier to expertise for NMR Spectroscopy. This qNMR software module was specifically targeted as a solution to address the last pain point. By allowing admin to set up QA/QC methods that technicians can select to yield processed and analyzed quantitative data address one of the main obstacles that hinder use of NMR in QA/QC.'.

Nanalysis副总裁兼市场营销与NMR产品经理表示：“为了将我们紧凑便携的台式NMR平台扩展到工业质量保证/质量控制（QA/QC）领域，我们采用了四项策略：1）识别并验证那些能为将现有方法现代化为台式NMR带来高投资回报率的方法；2）提供良好的数据处理实践以确保满足数据完整性要求；3）探索这些方法的法规合规性；最后，4）降低NMR光谱学的专业门槛。这个qNMR软件模块正是针对解决最后一个痛点而设计的解决方案。通过允许管理员设置QA/QC方法，让技术人员可以选择生成经过处理和分析的定量数据，从而解决了阻碍NMR在QA/QC中使用的主要障碍之一。”

'Nanalysis continues to provide innovative hardware and software solutions. By establishing great working relationships with key organizations in strategic sectors (e.g., pharmaceuticals, polymers, illicit drugs), over the next several years, we expect to execute many benchtop NMR regulatory methods with USP, ISO, etc..

Nanalysis持续提供创新的硬件和软件解决方案。通过与战略领域（如制药、聚合物、违禁药物）的关键机构建立良好的工作关系，我们预计在未来几年内将执行许多符合USP、ISO等标准的台式NMR监管方法。

Pairing validated methods with strong ROI with good data handling practices we can help drive the need for modernization of testing principles. We are also partnering with companies leading the charge towards Self Driving Labs (SDL) to supercharge innovation and reduce overall costs with automation, high throughput, and AI.

将经过验证的方法与强大的投资回报率和良好的数据处理实践相结合，我们可以推动测试原则现代化的需求。我们还与引领自助驾驶实验室（SDL）发展的公司合作，通过自动化、高通量和人工智能来加速创新并降低总体成本。

This in turn, will be a growth driver for QA/QC in the pharmaceutical and polymer markets,' concluded Dr. Riegel..

里格尔博士总结道：“这反过来将成为制药和聚合物市场中质量保证/质量控制的增长动力。”

About

关于

Nanalysis Scientific Corp.

纳分析科学公司

(TSXV: NSCI, OTCQX:

（TSXV：NSCI，OTCQX：

NSCIF

, FRA:1N1)

，法国：1N1）

Nanalysis Scientific Corp. in operates two primary business segments: Scientific Equipment and Security Services. Within its Scientific Equipment business is what the Company terms 'MRI and NMR for industry'. The Company develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets.

Nanalysis Scientific Corp.运营两个主要业务部门：科学设备和安全服务。在科学设备业务中，公司称之为“工业用核磁共振成像（MRI）和核磁共振（NMR）”。公司为实验室和工业市场开发和制造便携式核磁共振（NMR）光谱仪或分析仪。

The NMReady-60™ was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The Company has followed-up that initial offering with new products and continues to have a strong innovation pipeline. In 2020, the Company announced the launch of its 100MHz device, the most powerful and most advanced commercial compact NMR device ever brought to market. .

NMReady-60™ 是首款全功能便携式核磁共振波谱仪，集成于单一紧凑结构中，无需液氦或其他任何低温冷却剂。公司随后推出了新产品，并持续保持着强大的创新研发管线。2020年，公司宣布推出其100MHz设备，这是市场上有史以来最强大、最先进的商用紧凑型核磁共振设备。

The Company's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavor and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The Company is working to expand into new global market opportunities independently and with partners. With its partners, the Company provides scientific equipment sales and maintenance services globally. .

公司设备被广泛应用于多个行业（石油和天然气、化工、矿业、制药、生物技术、香料和香水、农用化学品、执法等），以及全球众多政府和大学研究实验室。公司正在独立拓展新的全球市场机遇，并与合作伙伴共同推进。通过与合作伙伴协作，公司在全球范围内提供科学设备的销售和维护服务。

In 2022 the Company was awarded a five-year,

2022年，公司被授予了为期五年的，

$160 million

1.6亿美元

contract to provide maintenance services for passenger screening equipment in Canadian airports. This has resulted in expansion of the Company's Security Services business. The Company is providing airport security equipment maintenance services in each province and territory of Canada. In addition, the Company provides commercial security equipment installation and maintenance services to a variety of customers in North America. .

签订合同，为加拿大机场的旅客安检设备提供维护服务。这使得公司的安全服务业务得到了扩展。公司正在加拿大各省和地区提供机场安全设备维护服务。此外，公司还为北美地区的各类客户提供商用安全设备的安装和维护服务。

Notice regarding Forward Looking Statements and Legal Disclaimer

关于前瞻性陈述和法律声明的通知

This news release contains certain 'forward-looking statements' within the meaning of such statements under applicable securities law. Forward-looking statements are frequently characterized by words such as 'anticipates', 'plan', 'continue', 'expect', 'project', 'intend', 'believe', 'anticipate', 'estimate', 'may', 'will', 'potential', 'proposed', 'positioned' and other similar words, or statements that certain events or conditions 'may' or 'will' occur.

本新闻稿包含某些适用证券法下定义的“前瞻性陈述”。前瞻性陈述通常通过诸如“预期”、“计划”、“继续”、“预计”、“项目”、“打算”、“相信”、“估计”、“可能”、“将”、“潜在”、“建议”、“定位”等词语以及其他类似的词语来描述，或表明某些事件或条件“可能”或“将会”发生。

These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements.

这些声明仅为预测。在得出本新闻稿中包含的前瞻性声明中的结论或进行预测时，使用了各种假设。前瞻性声明基于管理层在声明作出时的意见和估计，并受到多种风险、不确定性和其他因素的影响，这些因素可能导致实际事件或结果与前瞻性声明中预测的内容存在重大差异。

The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law..

公司没有任何义务，也明确否认任何更新或修改任何前瞻性陈述的意图或义务，无论是否由于新信息、未来事件或其他原因，除非适用法律明确要求。

Neither TSX Venture Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

多伦多证券交易所创业板及其监管服务提供商均不对本公告的充分性或准确性承担责任。

SOURCE Nanalysis Scientific Corp.

来源：Nanalysis Scientific Corp.

WANT YOUR COMPANY'S NEWS

想要贵公司的新闻吗

FEATURED ON PRNEWSWIRE.COM?

刊登在PRNEWSWIRE.COM上？

440k+

44万+

Newsrooms &